[1] Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: Results from olmsted county, minnesota. Arthritis and rheumatism. 2010; 62(6): 1576-82.
[2] Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376(9746): 1094-108.
[3] Viatte S, Barton A. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Semin Immunopathol. 2017; 39(4): 395-408.
[4] Groves C, Chandramohan M, Chew NS, Aslam T, Helliwell PS. Clinical examination, ultrasound and mri imaging of the painful elbow in psoriatic arthritis and rheumatoid arthritis: Which is better, ultrasound or mr, for imaging enthesitis? Rheumatol Ther. 2017; 4(1): 71-84.
[5] Kourilovitch M, Galarza-Maldonado C, Ortiz-Prado E. Diagnosis and classification of rheumatoid arthritis. Journal of Autoimmunity. 2014; 48-49: 26-30.
[6] De Cock D, Hyrich K. Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management. Best Pract Res Clin Rheumatol. 2018; 32(6): 869-86.
[7] Misiuniene N, Baranauskaite A. [diagnosis and treatment of rheumatoid arthritis]. Medicina (Kaunas). 2002; 38(1): 110-6.
[8] Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. Ncbi geo: Archive for functional genomics data sets--update. Nucleic Acids Res. 2013; 41(Database issue): D991-5.
[9] Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019, 37(7): 773-82.
[10] Harrison WT, Yeates RM, Phillips ML, Nenoff TM. New framework connectivity patterns in templated networks: The creatinine zinc phosphites c4n3oh7.Znhpo3, c4n3oh7.Zn(h2o)hpo3, and (c4n3oh7)2.Znhpo3.H2o. Inorg Chem. 2003, 42(5): 1493-8.
[11] Choy E. Understanding the dynamics: Pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2012; 51 Suppl 5: v3-11.
[12] Liu L, Wong CW, Han M, Farhoodi HP, Liu G, Liu Y, et al. Meta-analysis of preclinical studies of mesenchymal stromal cells to treat rheumatoid arthritis. EBioMedicine. 2019; 47: 563-77.
[13] Smolen JS, Aletaha D, Redlich K. The pathogenesis of rheumatoid arthritis: New insights from old clinical data? Nat Rev Rheumatol. 2012; 8(4): 235-43.
[14] Raterman HG, Vosslamber S, de Ridder S, Nurmohamed M T, Lems W F, Boers M, et al. The interferon type i signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res Ther. 2012; 14(2): R95.
[15] Stuhlmuller B, Haupl T, Hernandez MM, Grutzkau A, Kuban RJ, Tandon N, et al. Cd11c as a transcriptional biomarker to predict response to anti-tnf monotherapy with adalimumab in patients with rheumatoid arthritis. Clin Pharmacol Ther. 2010; 87(3): 311-21.
[16] Fraser A, Vallow J, Preston A, Cooper RG. Predicting 'normal' grip strength for rheumatoid arthritis patients. Rheumatology (Oxford). 1999; 38(6): 521-8.
[17] Stenstrom CH, Minor MA. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis and rheumatism. 2003; 49(3): 428-34.
[18] Yamada T, Steinz MM, Kenne E, Lanner JT. Muscle weakness in rheumatoid arthritis: The role of ca(2+) and free radical signaling. EBioMedicine. 2017; 23: 12-19.
[19] Zheng Z, Mergaert AM, Fahmy LM, Bawadekar M, Holmes CL, Ong IM, et al. Disordered antigens and epitope overlap between anti-citrullinated protein antibodies and rheumatoid factor in rheumatoid arthritis. Arthritis Rheumatol. 2019.
[20] Edhayan G, Ohara RA, Stinson WA, Amin MA, Isozaki T, Ha CM, et al. Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis. Arthritis Res Ther. 2016; 18: 87.
[21] Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 2008; 319(5860): 195-8.
[22] Simon A, Subra JF, Guilpain P, Jeannin P, Pignon P, Blanchard S, et al. Detection of anti-pentraxin-3 autoantibodies in anca-associated vasculitis. PloS one. 2016; 11(1): e0147091-e91.
[23] Bartok B, Firestein GS. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1): 233-55.
[24] Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica. 2010; 5(4): 286-91.
[25] Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017; 46(2): 183-96.
[26] Kleinert S, Waldner M, Wendler J, Kunzmann V. [disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer]. Z Rheumatol. 2016; 75(1): 41-6.
[27] Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008; 118(11): 3537-45.
[28] Feldmann M, Maini RN. Anti-tnf alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol. 2001; 19: 163-96.
[29] Dixon WG, Symmons DP. What effects might anti-tnfalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of tnfalpha in cardiovascular pathophysiology. Ann Rheum Dis. 2007; 66(9): 1132-6.
[30] Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003; 108(24): 2957-63.
[31] Li XF, Sun YY, Bao J, Chen X, Li YH, Yang Y, et al. Functional role of ppar-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Scientific reports. 2017; 7(1): 12671-71.
[32] Brenner M, Linge CP, Li W, Gulko PS. Increased synovial expression of nuclear receptors correlates with protection in pristane-induced arthritis: A possible novel genetically regulated homeostatic mechanism. Arthritis & Rheumatism. 2011; 63(10): 2918-29.
[33] Brenner M, Laragione T, Gulko PS. Short-term low-magnesium diet reduces autoimmune arthritis severity and synovial tissue gene expression. Physiological Genomics. 2017; 49(4): 238-42.
[34] Yamasaki S, Nakashima T, Kawakami A, Miyashita T, Tanaka F, Ida H, et al. Cytokines regulate fibroblast-like synovial cell differentiation to adipocyte-like cells. Rheumatology. 2004; 43(4): 448-52.
[35] Liu Y, Qu Y, Liu L, Zhao H, Ma H, Si M, et al. Ppar-γ agonist pioglitazone protects against il-17 induced intervertebral disc inflammation and degeneration via suppression of nf-κb signaling pathway. Int Immunopharmacol. 2019; 72: 138-47.
[36] Li XF, Sun YY, Bao J, Chen X, Li YH, Yang Y, et al. Functional role of ppar-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Sci Rep. 2017; 7(1): 12671.
[37] Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, et al. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. J Am Heart Assoc. 2013; 2(6): e000441.
[38] Samimi Z, Kardideh B, Zafari P, Bahrehmand F, Roghani S, Taghadosi M. The impaired gene expression of adenosine monophosphate-activated kinase (ampk), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients. Molecular Biology Reports $V OnlineFirst. 2019: 1-8.
[39] Baillet A, Trocmé C, Berthier S, Arlotto M, Grange L, Chenau J, et al. Synovial fluid proteomic fingerprint: S100a8, s100a9 and s100a12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology. 2010; 49(4): 671-82.
[40] Hurnakova J, Hulejova H, Zavada J, Hanova P, Komarc M, Mann H, et al. Relationship between serum calprotectin (s100a8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study. PloS one. 2017; 12(8): e0183420-e20.
[41] Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, et al. Induction of the p16ink4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med. 1999; 5(7): 760-67.
[42] Murakami Y, Mizoguchi F, Saito T, Miyasaka N, Kohsaka H. P16ink4a exerts an anti-inflammatory effect through accelerated irak1 degradation in macrophages. The Journal of Immunology. 2012; 189(10): 5066.
[43] Schmitz M L, Kracht M. Cyclin-dependent kinases as coregulators of inflammatory gene expression. Trends in Pharmacological Sciences. 2016; 37(2): 101-13.
[44] Avci AB, Feist E, Burmester GR. Targeting il-6 or il-6 receptor in rheumatoid arthritis: What's the difference? BioDrugs. 2018; 32(6): 531-46.
[45] Schett G. Physiological effects of modulating the interleukin-6 axis. Rheumatology (Oxford). 2018; 57(suppl_2): ii43-ii50.
[46] Yuan FL, Li X, Lu WG, Sun JM, Jiang DL, Xu RS. Epidermal growth factor receptor (egfr) as a therapeutic target in rheumatoid arthritis. Clin Rheumatol. 2013; 32(3): 289-92.
[47] Rapley J, Nicolàs M, Groen A, Regué L, Bertran MT, Caelles C, et al. The nima-family kinase nek6 phosphorylates the kinesin eg5 at a novel site necessary for mitotic spindle formation. Journal of Cell Science. 2008; 121(23): 3912.
[48] Cahu J, Olichon A, Hentrich C, Schek H, Drinjakovic J, Zhang C, et al. Phosphorylation by cdk1 increases the binding of eg5 to microtubules in vitro and in xenopus egg extract spindles. PloS one. 2008; 3(12): e3936.
[49] Bertran MT, Sdelci S, Regué L, Avruch J, Caelles C, Roig J. Nek9 is a plk1-activated kinase that controls early centrosome separation through nek6/7 and eg5. The EMBO Journal. 2011; 30(13): 2634-47.
[50] Shiozawa S, Tsumiyama K. Pathogenesis of rheumatoid arthritis and c-fos/ap-1. Cell Cycle. 2009; 8(10): 1539-43.
[51] Pap T, Nawrath M, Heinrich J, Bosse M, Baier A, Hummel KM, et al. Cooperation of ras- and c-myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis and rheumatism. 2004; 50(9): 2794-802.
[52] de Hair MJ, van de Sande MG, Ramwadhdoebe TH, Hansson M, Landewé R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: Implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014, 66(3): 513-22.
[53] Huang R, Wu J, Zheng Z, Wang G, Song D, Yan P, et al. The construction and analysis of cerna network and patterns of immune infiltration in mesothelioma with bone metastasis. Front Bioeng Biotechnol. 2019, 7: 257.